←Back to Expert Scholars
Translational Medicine / 转化医学Rare Pediatric Solid Tumors, Neuroblastoma and Rare Tumors
Jaume Mora
MD, PhD
🏢Hospital Sant Joan de Deu Barcelona🌐Spain
Scientific Director, Pediatric Cancer Center Barcelona
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jaume Mora is scientific director of the Pediatric Cancer Center in Barcelona and a leader in rare pediatric solid tumor care. He led development of naxitamab (anti-GD2) and trials in high-risk neuroblastoma. His program serves as a European referral center for rare pediatric cancers.
Share:
🧪Research Fields 研究领域
neuroblastoma
rare pediatric tumors
pediatric sarcomas
naxitamab
GD2 antibody therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jaume Mora 的研究动态
Follow Jaume Mora's research updates
留下邮箱，当我们发布与 Jaume Mora（Hospital Sant Joan de Deu Barcelona）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment